Immunotherapy Combination Approved for First-Line Kidney Cancer Treatment April 16, 2018October 31, 2024 Arthur N. Brodsky, PhD
Preview Immunotherapy Highlights from AACR 2018 Annual Meeting April 12, 2018October 31, 2024 Arthur N. Brodsky, PhD
Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD
Immuno-Oncology 360°: Taking Immunotherapy to the Next Level February 6, 2018December 14, 2022 Arthur N. Brodsky, PhD